In agreement with our data on the IκBa mutant, Wu et al [35] recently reported that the IκB kinase inhibitor BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks. Here, NFKBIA is linked to breast cancer.